Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Mediterranean Journal of Rheumatology|September 21, 2022
Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational StudyMaria Pappa, Maria Kosmetatou, Antonia Elezoglou, et al.
Rheumatology International|August 23, 2023
Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective studyNikolaos Kougkas, Konstantina Magiouf, Chrysoula G Gialouri, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 1, 2023
Microelectrode Arrays Measure Blocking of Voltage-Gated Calcium Ion Channels on Supported Lipid Bilayers Derived from Primary NeuronsZixuan Lu, Chiara Barberio, Ana Fernandez-Villegas, et al.
Mediterranean Journal of Rheumatology|November 16, 2020
Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 PandemicGeorge E Fragoulis, Gerasimos Evangelatos, Aikaterini Arida, et al.
Rheumatology International|November 5, 2021
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional studyGeorge E Fragoulis, Vassiliki-Kalliopi Bournia, Eugenia Mavrea, et al.
Lupus Science & Medicine|May 27, 2026
Beyond renal response: sustained systemic disease control protects against adverse long-term outcomes in lupus nephritisKonstantinos Drougkas, Spyridon Katechis, Myrto Kostopoulou, et al.
Rheumatology International|January 3, 2025
Similar Hepatitis B virus reactivation risk for patients with inflammatory arthritis or connective tissue diseases: a multicenter retrospective studyMaria Pappa, Alexandra Koutsogianni, Anastasios Karamanakos, et al.
Rheumatology International|March 4, 2021
Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional studyGeorge E Fragoulis, Ioannis Grigoropoulos, Evgenia Mavrea, et al.
Journal of Autoimmunity|December 3, 2021
Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosisNikolaos I Vlachogiannis, Simon Tual-Chalot, Eleftherios Zormpas, et al.
Pageof 10